Unlock Full Company Report
Access verified contacts, investors & buying signals.
Recently Funded|Amount: EUR 525.0K|Industry: Biotechnology Research
Genbioma Aplicaciones Secures $525K to Advance Precision Microbiome Solutions for Metabolic Health and Diabetes Care
Genbioma Aplicaciones

View Full Report
Includes contacts, investors & buying signals
Genbioma Aplicaciones is excited to announce a milestone funding round, having raised 525,000 to further its mission of advancing microbiome-based products aimed at improving metabolism and human health. This significant investment underscores the growing recognition of the company's innovative approach in addressing a range of metabolic disorders that affect millions worldwide. With its groundbreaking work in personalised nutrition for diabetes-related conditions, obesity, and other metabolic disturbances, Genbioma Aplicaciones is steadfast in its commitment to transforming health outcomes through science and innovation. The new funds will be strategically directed towards scaling both existing and new initiatives, including the development of a fast preclinical model designed to meticulously study the mechanisms of action (MoA) on health. Leveraging this advanced platform, the company is set to refine its precision probiotic pA1c® (featuring live strains) and its inactivated postbiotic pA1c®HI, tailored for various diabetes-related conditions, ranging from pre-diabetes to type 2 and gestational diabetes. Additionally, the funding will enhance research and development efforts surrounding postbiotics specifically targeting lipid metabolism disorders, which include obesity and dyslipidemias. Furthermore, Genbioma Aplicaciones plans to invest in its novel fast prescreening platform technology aimed at rapidly identifying new beneficial strains and exploring other health targets such as longevity, antioxidant capabilities, and anti-inflammatory properties. This comprehensive strategy not only accelerates the pathway for innovative therapeutic solutions but also reinforces the company’s position at the forefront of precision medicine. As Genbioma Aplicaciones continues to break new ground in metabolic health, this funding round marks a pivotal step in its journey towards revolutionizing healthcare outcomes for a global community.
Buying Signals & Intent
Our AI suggests Genbioma Aplicaciones may be interested in solutions related to:
- Research and Development
- Dietary Supplements
- Food Products
- Medical Research
- Microbiome Technology
Sell these products?
Unlock full report to find contacts.
Investors
Unlock Investor Data
See who invested in Genbioma Aplicaciones and potentially find related investment contacts.
Unlock Premium AccessKey Decision Makers
Unlock Verified Contacts
Get direct email addresses and phone numbers for key decision makers at Genbioma Aplicaciones.
Unlock Contacts Now